logo

FHI

Federated Hermes·NYSE
--
--(--)
--
--(--)
5.48 / 10
Netural

FHI's fundamental health is average (score 5.5/10). Strengths include robust YoY growth in basic and diluted EPS (58.8%) and a high gross margin (90.0%). Key concerns are negative returns on total assets (-9.6%) and a current liabilities/total liabilities ratio of 32.5%, signaling potential efficiency and leverage issues. Net income-revenue is positive, but asset-mv is negative, further highlighting underperformance in asset utilization. Overall, the fundamentals are mixed, warranting a neutral view.

Fundamental(5.48)SentimentTechnical

Analysis Checks(5/10)

Gross profit margin (%)
Value90.04
Score3/3
Weight18.29%
1M Return4.30%
Current liabilities / Total liabilities (%)
Value32.52
Score1/3
Weight5.91%
1M Return1.55%
Net income-Revenue
Value0.55
Score2/3
Weight6.94%
1M Return1.88%
Basic earnings per share (YoY growth rate %)
Value58.82
Score3/3
Weight20.43%
1M Return4.30%
Rate of return on total assets (%)
Value-9.58
Score1/3
Weight5.85%
1M Return1.48%
Total profit / EBIT (%)
Value100.00
Score3/3
Weight8.55%
1M Return2.19%
Annualized return on total assets (%)
Value-9.58
Score1/3
Weight5.85%
1M Return1.48%
Diluted earnings per share (YoY growth rate %)
Value58.82
Score3/3
Weight23.75%
1M Return4.99%
Operating revenue (YoY growth rate %)
Value10.33
Score1/3
Weight5.14%
1M Return1.29%
Asset-MV
Value-0.51
Score1/3
Weight-0.73%
1M Return-0.20%
Is FHI undervalued or overvalued?
  • FHI scores 5.48/10 on fundamentals and holds a Fair valuation at present. Backed by its 33.41% ROE, 23.00% net margin, 10.02 P/E ratio, 3.20 P/B ratio, and 58.82% earnings growth, these metrics solidify its Netural investment rating.